ESEuropeanSwitch
ME

Merus

Merus is a Dutch clinical-stage oncology company developing bispecific antibody treatments using its Biclonics technology platform for cancer patients.

Netherlands Founded 2003 Pay-as-you-go
🏢
Is this your company? Claim this listing to update your profile and add your logo. Free to claim — Enhanced Profile from £500 / €575 per year. See an example →

About Merus

Merus is a Dutch clinical-stage oncology company developing bispecific antibody treatments using its Biclonics technology platform for cancer patients.

Provider Details

HQ Netherlands
HQ City Utrecht
Founded 2003
Pricing Pay-as-you-go
Data Hosting Utrecht

Classifications